Volume 2 - Issue 4 - July/August 2005
Feature
Case Report
09/05/2008
Radiation-induced vasculitis (RIV) is a well-documented complication in patients with a history of previous head and neck or mediastinal radiation. Cardiac valves and ostial location lesions of the epicardial coronary arteries are the more...
Radiation-induced vasculitis (RIV) is a well-documented complication in patients with a history of previous head and neck or mediastinal radiation. Cardiac valves and ostial location lesions of the epicardial coronary arteries are the more...
Radiation-induced vasculitis...
09/05/2008
Vascular Disease Management
Case Report
09/05/2008
Iatrogenic renal artery perforation is a rare, but well-described complication of percutaneous renal artery intervention. Treatment has traditionally involved surgical intervention including renal artery reconstruction, bypass grafting, and...
Iatrogenic renal artery perforation is a rare, but well-described complication of percutaneous renal artery intervention. Treatment has traditionally involved surgical intervention including renal artery reconstruction, bypass grafting, and...
Iatrogenic renal artery...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
The association of internal carotid artery disease (ICAD) with aortic valve stenosis (AVS) constitutes a very high-risk clinical occurrence of which surgical management is still unclear, because the rate of death and stroke for combined...
The association of internal carotid artery disease (ICAD) with aortic valve stenosis (AVS) constitutes a very high-risk clinical occurrence of which surgical management is still unclear, because the rate of death and stroke for combined...
The association of internal...
09/05/2008
Vascular Disease Management
Case Report
09/05/2008
With the emerging data from ongoing trials demonstrating at least clinical equipoise with CEA, it is only a matter of time before carotid angioplasty and stenting becomes the procedure of choice for patients with atherosclerotic carotid...
With the emerging data from ongoing trials demonstrating at least clinical equipoise with CEA, it is only a matter of time before carotid angioplasty and stenting becomes the procedure of choice for patients with atherosclerotic carotid...
With the emerging data from...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
Peripheral stents aim to support revascularization procedures of intravascular stenoses by mechanically preventing vessel recoil and counteracting pathophysiologic processes of luminal re-narrowing triggered by procedural injury of the vessel...
Peripheral stents aim to support revascularization procedures of intravascular stenoses by mechanically preventing vessel recoil and counteracting pathophysiologic processes of luminal re-narrowing triggered by procedural injury of the vessel...
Peripheral stents aim to support...
09/05/2008
Vascular Disease Management
Original Research
09/05/2008
We report the use of an Angio-Seal™ Vascular Closure Device (St. Jude Medical, Minnetonka, MN) to close the arterial puncture site of the left subclavian artery (LSA) during inadvertent central line placement.
We report the use of an Angio-Seal™ Vascular Closure Device (St. Jude Medical, Minnetonka, MN) to close the arterial puncture site of the left subclavian artery (LSA) during inadvertent central line placement.
We report the use of an...
09/05/2008
Vascular Disease Management
Insights
Commentary
09/05/2008
Is this technology “hocus-pocus,” or the real thing, as we are certainly in great need of weapons to fight the war against critical limb ischemia (CLI).
Is this technology “hocus-pocus,” or the real thing, as we are certainly in great need of weapons to fight the war against critical limb ischemia (CLI).
Is this technology...
09/05/2008
Vascular Disease Management
Column
Editor's Corner
09/05/2008
The FDA announced approval of the first thoracic endograft device (Gore TAG) on March 23, 2005. It signaled the true beginning of a new era in endovascular therapy, and the unmistakable 'message' that thoracic aortic surgery is about to be...
The FDA announced approval of the first thoracic endograft device (Gore TAG) on March 23, 2005. It signaled the true beginning of a new era in endovascular therapy, and the unmistakable 'message' that thoracic aortic surgery is about to be...
The FDA announced approval of...
09/05/2008
Vascular Disease Management
